Diagnosed with Stage 4c bowel cancer at just 27, Taylor has firsthand experience with how powerful the outcomes of cutting-edge research can be.
"Things looked very bad for a few months, and I was faced with the real possibility of dying.
Luckily, I was eligible for an immunotherapy trial and after just eight months on the trial, my disease was classed as stable! We thought it was the best news we could hope for. But then, my tumours and nodes just kept shrinking!
In May 2022, after 20 rounds and 20 months of immunotherapy, my oncologist gave me the amazing news that I’d had a complete metabolic response to the treatment. I had no evidence of disease!" ~ Taylor. |
|
